CDD0102 is used as a potent and selective M1 muscarinic receptor agonist for the treatment of cognitive deficits, particularly in reversing memory impairments associated with IgG-192 saporin administration; it crosses the blood-brain barrier in a dose-dependent manner and shows minimal side effects at therapeutic doses.